liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
The roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammation
McGill University.
McGill University.
Linköping University, Department of Clinical and Experimental Medicine, Clinical Chemistry. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Centre for Laboratory Medicine, Department of Clinical Chemistry.
McGill University.
2009 (English)In: NEUROPHARMACOLOGY, ISSN 0028-3908, Vol. 56, no 3, 684-691 p.Article in journal (Refereed) Published
Abstract [en]

Animal models of inflammatory pain are characterized by the release of inflammatory mediators such as cytokines and neurotrophic factors, and enhanced analgesic sensitivity to opioids. In this study, we examine the mechanisms underlying this effect, in particular the roles of cholecystokinin (CCK) and nerve growth factor (NGF), in an animal model of central nervous system (CNS) inflammation induced by spinal administration of lipopolysaccharide (LPS). Although spinal administration of LY-225910 (25 ng), a CCK-B antagonist, enhanced morphine analgesia in naive rats, it was unable to do so in LPS-treated animals. Conversely, spinal CCK-8S administration (1 ng) decreased morphine analgesia in LPS-treated rats, but not in naive animals. Further, spinal anti-NGF (3 mu g) was able to reduce morphine analgesia in LPS-treated rats, but not in naive animals, an effect that was reversed by spinal administration of LY225910. While CCK-8S concentration was increased in spinal cord extracts of LPS animals as compared to controls, morphine-induced spinal CCK release in the extracellular space, as measured by in-vivo spinal cord microdialysis was inhibited in LIPS animals as compared to controls, and this was reversed by anti-NGF pretreatment. Finally, chronic spinal administration of beta-NGF (7 mu g/day) for 7 days enhanced spinal morphine analgesia, possibly by mimicking a CNS inflammatory state. We suggest that in intrathecally LPS-treated rats, spinal CCK release is altered resulting in enhanced morphine analgesia, and that this mechanism may be regulated to an important extent by NGF.

Place, publisher, year, edition, pages
2009. Vol. 56, no 3, 684-691 p.
Keyword [en]
CNS inflammation, Lipopolysaccharide, Thermal hyperalgesia, Nerve growth factor, Cholecystokinin, In-vivo microdialysis, Spinal cord
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-17279DOI: 10.1016/j.neuropharm.2008.12.002OAI: diva2:208132
Available from: 2009-03-16 Created: 2009-03-16 Last updated: 2009-08-21

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Theodorsson, Elvar
By organisation
Clinical ChemistryFaculty of Health SciencesDepartment of Clinical Chemistry
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 17 hits
ReferencesLink to record
Permanent link

Direct link